Kinectrics Holdings Inc.
Total Consideration
$440.6M
Purchase-Price Allocation
Goodwill
$130.1M
Intangibles
$151.3M
BWX TECHNOLOGIES, INC. — Key Metrics
3 years of history · ending 2025-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
M-Score (Beneish; >-1.78 flags risk)
Z-Score (Altman; <1.81 = distress)
Per Share Metrics
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
Valuation Multiples
Cash-Flow Multiples
Enterprise Value Multiples
52-Week Range
Trailing Returns
ROIC vs WACC
Yields
Capital Deployment Yields
Liquidity & Leverage Ratios
Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)
EPS (Diluted)
$4
Book Value Per Share
$13
Free Cash Flow Per Share
$3
Cash Per Share
$5
Revenue Per Share
$35
OCF Per Share
$5
Return on Equity
28.4%
Return on Assets
9.2%
Return on Invested Capital
12.5%
Debt to Equity
1.64
Current Ratio
2.32
Quick Ratio
2.25
Asset Turnover
0.90
Days Sales Outstanding
25.15
Days Payables Outstanding
20.92
Days Inventory On Hand
6.89
Cash Conversion Cycle
11.12
R&D / Revenue
0.4%
SBC / Revenue
0.8%
Capex / Revenue
5.8%
Working Capital
$888M
Net Current Asset Value
$-1.48B
Invested Capital
$3.25B
OCF / Net Income
1.46
FCF / Net Income
0.90
Accruals Ratio (Sloan)
-3.5%
Net Debt
$1.52B
Net Debt / EBITDA
2.95
Interest Coverage
89.09
Cash Coverage
105.69
Dividend Coverage
5.19
Capex Coverage
2.60
Tangible Common Equity
$402M
TCE / Total Assets
9.4%
Goodwill / Total Assets
11.7%
NOPAT
$335M
Cash ROIC
11.0%
WC / Revenue
27.8%
Capex / D&A
1.69
Reinvestment Rate
150.9%
Total Payout Ratio
37.2%
Asset Growth vs Revenue Growth
30.5%
Revenue 5Y CAGR
8.5%
EPS 5Y CAGR
3.4%
FCF 5Y CAGR
21.2%
EBITDA 5Y CAGR
4.1%
Book Value 5Y CAGR
14.8%
Stock Price (FY-end)
$173
Market Cap
$15.85B
P/E Ratio
48.20
P/S Ratio
4.96
P/B Ratio
12.86
P/TB Ratio
39.46
P/OCF Ratio
33.04
P/FCF Ratio
53.69
Enterprise Value
$17.37B
EV / EBITDA
33.82
EV / Sales
5.43
EV / FCF
58.83
FCF Yield
1.9%
Dividend Yield
0.6%
Shareholder Yield
0.6%
Buyback Yield
0.2%
R&D Yield
0.1%
Capex Yield
1.2%
Dividend Per Share
$1
DPS YoY Growth
4.7%
Operating Leverage
0.34
Graham Number
$33
Shares Variation (YoY)
-0.0%
Beta (5Y)
0.82
Cost of Equity
8.6%
Cost of Debt (after tax)
0.2%
WACC
7.6%
ROIC - WACC Spread
4.8%
52W High
$215
52W Low
$89
Trailing Return 1Y
54.8%
Trailing Return 5Y
200.2%
F-Score (Piotroski)
5.00
M-Score (Beneish)
-1.66
Z-Score (Altman)
5.27
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.
EPS — Consensus vs Actual
Revenue — Consensus vs Actual
Beat / Miss vs Estimate
Stock Price on Earnings Dates
BWX TECHNOLOGIES, INC. — Effective Tax Rate ReconciliationNEW
Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.
Effective Rate Trend
| Reconciliation Line | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Federal Statutory Rate | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% | 21.00% |
| State & Local Income Taxes | 1.90% | 1.10% | 1.70% | 1.20% | 1.30% | 0.60% |
| Foreign Rate Differential | 0.60% | 0.60% | 0.50% | 0.50% | — | — |
| Other Adjustments | -0.30% | 0.00% | 1.50% | 1.50% | 1.20% | — |
| R&D Tax Credits | — | — | 0.00% | 0.00% | 4.00% | 1.40% |
| Nondeductible Expenses | — | — | — | — | — | -0.30% |
| Valuation Allowance Change | — | — | — | — | — | — |
| Tax Law Change | — | — | — | — | — | 0.00% |
| Qualified Production Activities (Legacy DPAD) | — | — | — | — | — | — |
| Effective Tax Rate | 22.90% | 22.60% | 24.10% | 23.40% | 19.00% | 17.10% |
Cash vs Accrual
| Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Income Tax Expense (Accrual) | $83.0M | $89.4M | $75.8M | $75.1M | $66.4M | $68.3M |
| Income Taxes Paid (Cash) | $73.6M | $44.9M | $71.8M | $84.5M | $45.5M | $47.9M |
BWX TECHNOLOGIES, INC. — M&A AcquisitionsNEW
Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.
Aerojet Ordnance Tennessee Inc.
Total Consideration
$101.1M
Purchase-Price Allocation
Goodwill
$75.0M